#Cancerdetection

A new research breakthrough has introduced a blood test capable of detecting tumor-derived cell-free RNA with remarkable sensitivity, potentially revolutionizing the approach to cancer diagnosis and monitoring in Thailand and around the globe. The study, recently highlighted in Medical Xpress, outlines how scientists have developed a test that can identify even minuscule traces of RNA released by cancer cells into the bloodstream, leading to the possibility of earlier and less invasive cancer detection.

A new blood test can detect tumor-derived cell-free RNA with notable sensitivity, potentially transforming cancer diagnosis and monitoring for Thai patients and beyond. Researchers describe a method that identifies tiny traces of RNA released by cancer cells into the bloodstream, opening the door to earlier, less invasive detection.

Cancer remains a leading health challenge in Thailand, where late-stage diagnoses often limit treatment options and worsen outcomes. The test targets fragments of tumor-derived RNA, which carry genetic instructions from DNA to cells, offering a chance to spot cancer at its earliest, most treatable moments.